Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Hybrid Type 1 Effectiveness-Implementation Randomized Controlled Trial of NeoMayor, a Mobile Health Intervention to Improve Cardiovascular Health in Chilean Older Adults

NCT07633392 is registered in ClinicalTrials.gov with University of Chile as lead sponsor.

NCT NCT07633392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07633392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Hybrid Type 1 Effectiveness-Implementation Randomized Controlled Trial of NeoMayor, a Mobile Health Intervention to Improve Cardiovascular Health in Chilean Older Adults
Lead sponsor
University of Chile
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
May 31, 2027
Enrollment
240 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, body mass index, cardiovascular health status, diet quality, fasting glucose, ldl cholesterol, physical activity, sleep duration, smoking status, urinary albumin-to-creatinine ratio